Carmat SA 2023 Achievements and 2024 Outlook Call Transcript
©-
Hi. Good morning. Good evening to everybody, and welcome to the business update and outlook about CARMAT tonight.
So the speakers altogether with me tonight are Dr. Anne-Céline Martin, working in Pompidou in Paris. She's a cardiologist. We have Pascale d'Arbonneau on my left, who's our Chief Financial Officer. We have Dr. Piet Jansen, our Chief Medical Officer; and Francesco Arecchi, the Director of Global Market Development.
So let's get started. So first, I will begin with the CARMAT 2023 achievements. So as a reminder, our mission is really a new way to solve the advanced heart failure transplant and destination therapy crisis. A very quick reminder, as you all know, between US and Europe, there is a need yearly of 200,000 transplant. And fortunately, they are much lesser implants organs available a year, around 6,000, 7,000. So only 3% of patients needing a treatment will be treated then most of the rest will die within a year.
So very quickly, the journey of CARMAT. So the company was born in 2008, and we've been
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
